If you are at risk for serious illness from COVID-19 and just tested positive, you should discuss treatment options with your healthcare provider, including taking antivirals.
How Antivirals Treat Respiratory Viruses
What to Expect
Antiviral medications can help your immune system fight back by helping stop the virus from multiplying your body. This lowers the amount of virus in your body with the goal of you having less severe symptoms and recovering more quickly. Antiviral therapy is not a cure for COVID-19. You are still contagious and can spread the virus to others. Be sure to monitor your symptoms and continue to self-isolate until 10 days have passed without using fever reducing medications, and your COVID-19 symptoms are improving.
What are My Treatment Options?
If you are recovering at home from mild-to-moderate COVID-19, you may qualify for one of these antiviral treatments depending on your age, health history and how long you’ve had symptoms. The following treatments are authorized for emergency use by the Food and Drug Administration:
- Paxlovid (nirmatrelvir/ritonavir): May be prescribed for adults and children who are at least 12 years old and weigh at least 88 lbs. It is not recommended for people with serious kidney or liver disease. This treatment is taken by mouth (as a pill) and must be given within five days after the first symptoms of COVID-19 appear.
- COVID-19 rebound is a recurrence of symptoms and a positive test after a negative result within 2-8 days of having finished Paxlovid. In these instances, continued monitoring of symptoms and additional periods of isolation are recommended.
- Lagevrio (molnupiravir): May be prescribed for adults 18 years and older. It is not recommended during pregnancy or when breastfeeding. This treatment is taken by mouth (as a pill) and must be given within five days after the first symptoms of COVID-19 appear.
- Veklury (remdesivir): May be prescribed for anyone over 28 days old. This treatment is administered via intravenous infusion (IV) at a treatment center for three consecutive days and must begin within seven days after the first symptoms of COVID-19 appear. This medication is also given to individuals hospitalized by COVID-19.
Talk with your healthcare provider about your treatment options. Based on your health history and symptoms, they can help you begin treatment if that is the best course of action. If antiviral medications are determined not to be the best treatment option for you, you might be a candidate for monoclonal antibodies, or be recommended supportive care at home unless your symptoms worsen.
Who is eligible?
Antiviral medication to treat COVID-19 is authorized for emergency use by the Food and Drug Administration (FDA) and used for patients who:
- test positive for COVID-19,
- are experiencing mild-moderate COVID-19 symptoms at home, and
- are high risk for severe illness that may result in hospitalization
Knowing if you are high-risk for severe illness from COVID-19 allows you to act quickly if you test positive for COVID-19 so you are less likely to develop severe illness requiring hospitalization. You may be high-risk if you are:
- 50 years or older,
- unvaccinated,
- a current or former smoker,
- overweight,
- diagnosed with chronic lung, heart, or kidney disease,
- diabetic,
- Pregnant, or
- immunocompromised
Where do I get antiviral treatment?
Antiviral medications require a prescription from a healthcare provider. If you are high risk for severe illness from COVID-19 and test positive, speak with your healthcare provider right away. You may also be prescribed antiviral medications directly from your pharmacist. Speak with your pharmacist if you have trouble getting in to see your primary care provider right away. Your symptoms must have started no later than within the last five days to begin treatment.
You can also visit a Test to Treat location, a clinic that is set up to confirm your COVID-19 diagnosis, review your medical history and prescribe appropriate treatment. If you still have questions about treatment, contact our Lung HelpLine staff at 800-LUNGUSA.
Additional Resources
Page last updated: April 18, 2024